Verrica Pharmaceuticals Inc.·4

Dec 9, 5:18 PM ET

Zawitz David 4

4 · Verrica Pharmaceuticals Inc. · Filed Dec 9, 2024

Insider Transaction Report

Form 4
Period: 2024-12-09
Zawitz David
Chief Operating Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-12-09+950,000950,000 total
    Exercise: $0.95Exp: 2034-12-09Common Stock (950,000 underlying)
Footnotes (1)
  • [F1]1/8th of the total shares subject to the option shall vest on June 9, 2025, and 1/48th of the total shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continuous service through such vesting date.

Documents

1 file
  • 4
    form4-12092024_101222.xmlPrimary